Review: Recent advances in contrast-enhanced near infrared diffuse optical imaging of diseases using indocyanine green

Journal of Near Infrared Spectroscopy

Volumn 20, Issue 1, 2012, Pages 203-221

  Grosenick, Dirk ^a   Wabnitz, Heidrun ^a   Ebert, Bernd ^a  

^a PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

Author keywords

Arthritis; Breast cancer; Cerebral perfusion; Contrast agents; Fluorescence imaging; Near infrared optical imaging

Indexed keywords

EID: 84859044847     PISSN: 09670335     EISSN: None     Source Type: Journal    
DOI: 10.1255/jnirs.964     Document Type: Review

References (99)

1. A.P. Gibson, J.C. Hebden and S.R. Arridge, "Recent advances in diffuse optical imaging", Phys. Med. Biol. 50, R1 (2005). doi:10.1088/0031-9155/50/4/R01 (Pubitemid 40309196)
2. P. Taroni, A. Torricelli, L. Spinelli, A. Pifferi, F. Arpaia, G. Danesini and R. Cubeddu, "Time-resolved optical mammography between 637 and 985 nm: Clinical study on the detection and identification of breast lesions", Phys. Med. Biol. 50, 2469 (2005). doi:10.1088/0031-9155/50/11/003 (Pubitemid 40770634)
3. D. Grosenick, K. Th. Moesta, M. Möller, J. Mucke, H. Wabnitz, B. Gebauer, Ch. Stroszczynski, B. Wassermann, P.M. Schlag and H. Rinneberg, "Timedomain scanning optical mammography: I. Recording and assessment of mammograms of 154 patients", Phys. Med. Biol. 50, 2429 (2005). doi:10.1088/0031-9155/50/11/001 (Pubitemid 40770632)
4. D. Floery, T.H. Helbich, C.C. Riedl, S. Jaromi, M. Weber, S. Leodolter and M.H. Fuchsjaeger, "Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience", Invest. Radiol. 40, 328 (2005). doi:10.1097/01.rli.0000164487. 60548.28 (Pubitemid 40734560)
5. R. Choe, S.D. Konecky, A. Corlu, K. Lee, T. Durduran, D.R. Busch, S. Pathak, B.J. Czerniecki, J. Tchou, D.L. Fraker, A. Demichele, B. Chance, S.A. Arridge, M. Schweiger, J.P. Culver, M.D. Schnall, M.E. Putt, M.A. Rosen and A.G. Yodh, "Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography", J. Biomed. Opt. 14, 024020 (2009). doi:10.1117/1.3103325
6. H. Obrig and A. Villringer, "Beyond the visible-imaging the human brain with light", J. Cereb. Blood Flow Metab. 23, 1 (2003). doi:10.1097/00004647-200301000-00001
7. M. Ferrari, L. Mottola and V. Quaresima, "Principles, techniques and limitations of near infrared spectroscopy", Can. J. Appl. Physiol. 29, 463 (2004). doi:10.1139/h04-031
8. S. Lloyd-Fox, A. Blasi and C.E. Elwell "Illuminating the developing brain: The past, present and future of functional near infrared spectroscopy", Neurosci. Biobehav. Rev. 34, 269 (2010).
9. M.S. Damian and R. Schlosser, "Bilateral near infrared spectroscopy in space-occupying middle cerebral artery stroke", Neurocritical Care 6, 165 (2007). doi:10.1007/s12028-007-0010-3 (Pubitemid 350239282)
10. D. Hargroves, R. Tallis, V. Pomeroy and A. Bhalla, "The Influence of positioning upon cerebral oxygenation after acute stroke: a pilot study", Age Ageing 37, 581 (2008). doi:10.1093/ageing/afn143
11. T. Durduran, C. Zhou, B.L. Edlow, G. Yu, R. Choe, M.N. Kim, B.L. Cucchiara, M.E. Putt, Q. Shah, S.E. Kasner, J.H. Greenberg, A.G. Yodh and J.A. Detre, "Transcranial optical monitoring of cerebrovascular hemodynamics in acute stroke patients", Opt. Expr. 17, 3884 (2009). doi:10.1364/OE.17. 003884
12. J.M. Canvin, S. Bernatsky, C.A. Hitchon, M. Jackson, M.G. Sowa, J.R. Mansfield, H.H. Eysel, H.H. Mantsch and H.S. El-Gabalawy, "Infrared spectroscopy: Shedding light on synovitis in patients with rheumatoid arthritis", Rheumatology (Oxford) 42, 76 (2003). doi:10.1093/rheumatology/ keg034 (Pubitemid 36131571)
13. A.K. Scheel, M. Backhaus, A.D. Klose, B. Moa-Anderson, U.J. Netz, K.G. Hermann, J. Beuthan, G.A. Müller, G.R. Burmester and A.H. Hielscher, "First clinical evaluation of sagittal laser optical tomography for detection of synovitis in arthritic finger joints", Ann. Rheum. Dis. 64, 239 (2005). doi:10.1136/ard.2004.024224 (Pubitemid 40193620)
14. K. Licha, B. Riefke, V. Ntziachristos, A. Becker, B. Chance and W. Semmler, "Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization", Photochem. Photobiol. 72, 392 (2000). doi:10.1562/0031-8655 (2000) 072<0392:HCDACA>2.0.CO;2
15. C. Perlitz, K. Licha, F.D. Scholle, B. Ebert, M. Bahner, P. Hauff, K.T. Moesta and M. Schirner, "Comparison of two tricarbocyanine-based dyes for fluorescence optical imaging", J. Fluoresc. 15, 443 (2005). doi:10.1007/s10895-005-2636-x (Pubitemid 40952250)
16. C. Bremer, V. Ntziachristos and R. Weissleder, "Opticalbased molecular imaging: Contrast agents and potential medical applications", Eur. Radiol. 13, 231 (2003). doi:10.1007/s00330-002-1610-0
17. R. Weissleder and V. Ntziachristos, "Shedding light onto live molecular targets", Nat. Med. 9, 123 (2003). doi:10.1038/nm0103-123 (Pubitemid 36098273)
18. S. van de Ven, A. Wiethoff, T. Nielsen, B. Brendel, M. Van der Voort, R. Nachabe, M. Van der Mark, M. van Beek, L. Bakker, L. Fels, S. Elias, P. Luijten and W. Mali, "A novel fluorescent imaging agent for diffuse optical tomography of the breast: First clinical experience in patients", Mol. Imaging Biol. 12, 343 (2010). doi:10.1007/s11307-009-0269-1
19. A. Poellinger, T. Persigehl, M. Mahler, M. Bahner, S.L. Ponder, F. Diekmann, C. Bremer and T. Moesta, "Nearinfrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial", Invest. Radiol. 46, 697 (2011). doi:10.1097/RLI.0b013e318229ff25
20. T. Desmettre, J.M. Devoisselle and S. Mordon, "Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography", Surv. Ophthalmol. 45, 15 (2000). doi:10.1016/S0039-6257 (00) 00123-5
21. K. Kamisaka, Y. Yatsuji, H. Yamada and H. Kameda, "The binding of indocyanine green and other organic anions to serum proteins in liver diseases", Clin. Chim. Acta 53, 255 (1974). doi:10.1016/0009-8981 (74) 90107-7
22. T.J. Muckle, "Plasma protein binding of indocyanine green", Biochem. Med. 15, 17 (1976). doi:10.1016/0006-2944 (76) 90069-7
23. S. Yoneya, T. Saito, Y. Komatsu, I. Koyama, K. Takahashi and J. Duvoll-Young, "Binding properties of indocyanine green in human blood", Invest. Ophthal. Visual Sci. 39, 1286 (1998).
24. M.L. Landsman, G. Kwant, G.A. Mook and W.G. Zijlstra, "Light-absorbing properties, stability and spectral stabilization of indocyanine green", J. Appl. Physiol. 40, 575 (1976).
25. R.C. Benson and H.A. Kues, "Fluorescence properties of indocyanine green as related to angiography", Phys. Med. Biol. 23, 159 (1978). doi:10.1088/0031-9155/23/1/017
26. B. Hollins, B. Noe and J.M. Henderson, "Fluorometric determination of indocyanine green in plasma", Clin. Chem. 33, 765 (1987).
27. S. Mordon, J.M. Devoisselle, S. Soulie-Begu and T. Desmettre, "Indocyanine green: physicochemical factors affecting its fluorescence in vivo", Microvasc. Res. 55, 146 (1998). doi:10.1006/mvre.1998.2068 (Pubitemid 28368700)
28. J. Malicka, I. Gryczynski, C.D. Geddes and J.R. Lakowicz, "Metal-enhanced emission from indocyanine green: a new approach to in vivo imaging", J. Biomed. Opt. 8, 472 (2003). doi:10.1117/1.1578643
29. A. Gerega, N. Zolek, T. Soltysinski, D. Milej, P. Sawosz, B. Toczylowska and A. Liebert, "Wavelength-resolved measurements of fluorescence lifetime of indocyanine green", J. Biomed. Opt. 16, 067010 (2011). doi:10.1117/1.3593386
30. W.J. Akers, M.Y. Berezin, H. Lee and S. Achilefu, "Predicting in vivo fluorescence lifetime behavior of near-infrared fluorescent contrast agents using in vitro measurements", J. Biomed. Opt. 13, 054042 (2008). doi:10.1117/1.2982535
31. R. Alford, H.M. Simpson, J. Duberman, G.C. Hill, M. Ogawa, C. Regino, H. Kobayashi and P.L. Choyke, "Toxicity of organic fuorophores used in molecular imaging: Literature review", Mol. Imaging 8, 341 (2009). doi:10.2310/7290.2009.00031
32. D.K.F. Meijer, B. Weert and G.A. Vermeer, "Pharmacokinetics of biliary excretion in man. VI. Indocyanine green", Eur. J. Clin. Pharmacol. 35, 295 (1988). doi:10.1007/BF00558268
33. P. Ott, S. Keiding, A.H. Johnsen and L. Bass, "Hepatic removal of two fractions of indocyanine green after bolus injection in anesthetized pigs", Am. J. Physiol. 266, 1108 (1994).
34. I.J. Fox, L.G.S. Brooker, D.W. Heseltime and E.H. Wood, "A new dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation", Circulation 14, 937 (1956).
35. E.C. Bradley and J.W. Barr, "Determination of blood volume using indocyanine green (cardio-green) dye", Life Sci. 7, 1001 (1968). doi:10.1016/0024-3205 (68) 90108-2
36. G.R. Cherrick, S.W. Stein, C.M. Leevy and C.S. Davidson, "Indocyanine green: Observations on its physical properties, plasma decay and hepatic extraction", J. Clin. Invest. 39, 592 (1960). doi:10.1172/JCI104072
37. S.G. Sakka, "Assessing liver function", Curr. Opin. Crit. Care. 13, 207 (2007). doi:10.1097/MCC.0b013e328012b268 (Pubitemid 46328337)
38. A.A. Chang, L.S. Morse and J.T. Handa, "Histologic localization of indocyanine green dye in aging primate and human ocular tissues with clinical angiographic correlation", Ophthalmology 105, 1060 (1998). doi:10.1016/S0161-6420 (98) 96008-0
39. B.E. Schaafsma, J.S. Mieog, M. Hutteman, J.R. van der Vorst, P.J. Kuppen, C.W. Löwik, J.V. Frangioni, C.J. van de Velde and A.L. Vahrmeijer, "The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery", J. Surg. Oncol. 104, 323 (2011). doi:10.1002/jso.21943
40. K. Polom, D. Murawa, Y.S. Rho, P. Nowaczyk, M. Hünerbein and P. Murawa, "Current trends and emerging future of indocyanine green usage in surgery and oncology: A literature review", Cancer 117, 4812 (2011). doi:10.1002/cncr.26087
41. B. Boné, M.K. Wiberg, B.K. Szabó, A. Szakos and R. Danielsson, "Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer", Acta Radiol. 44, 28 (2003). doi:10.1034/j.1600-0455.2003.00012.x
42. R.D. Rosenberg, B.C. Yankaskas, L.A. Abraham, E.A. Sickles, C.D. Lehman, B.M. Geller, P.A. Carney, K. Kerlikowske, D.S.M. Buist, D.L. Weaver, W.E. Barlow and R. Ballard-Barbash, "Performance benchmarks for screening mammography", Radiology 241, 55 (2006). doi:10.1148/radiol.2411051504 (Pubitemid 44433335)
43. P.A. Carney, D.L. Miglioretti, B.C. Yankaskas, K. Kerlikowske, R. Rosenberg, C.M. Rutter, B.M. Geller, L.A. Abraham, S.H. Taplin, M. Dignan, G. Cutter and R. Ballard-Barbash, "Individual and combined effects of age, breast density and hormone replacement therapy use on the accuracy of screening mammography", Ann. Intern. Med. 138, 168 (2003).
44. C.W. Piccoli, "Contrast-enhanced breast MRI: factors affecting sensitivity and specificity", Eur. Radiol. 7(Suppl. 5), S281 (1997). doi:10.1007/PL00006909
45. C. Kuhl, "The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice", Radiology 244, 356 (2007). doi:10.1148/radiol.2442051620 (Pubitemid 47080868)
46. E.E. Konofagou, "Quo vadis elasticity imaging?", Ultrasonics 42, 331 (2004). doi:10.1016/j.ultras.2003.11.010
47. A. Thomas, S. Kümmel, F. Fritzsche, M. Warm, B. Ebert, B. Hamm and T. Fischer, "Real-time sonoelastography performed in addition to B-mode ultrasound and mammography: improved differentiation of breast lesions?", Acad. Radiol. 13, 1496 (2006). doi:10.1016/j.acra.2006.08.012 (Pubitemid 44809997)
48. H. Rinneberg, D. Grosenick, K.T. Moesta, J. Mucke, B. Gebauer, C. Stroszczynski, H. Wabnitz, M. Möller, B. Wassermann and P.M. Schlag, "Scanning time-domain optical mammography: Detection and characterization of breast tumours in vivo", Technol. Cancer Res. Treat. 4, 483 (2005).
49. S. Kukreti, A.E. Cerussi, W. Tanamai, D. Hsiang, B.J. Tromberg and E. Gratton, "Characterization of metabolic differences between benign and malignant tumors: High-spectral-resolution diffuse optical spectroscopy", Radiology 254, 277 (2010). doi:10.1148/radiol.09082134
50. R. Ziegler, B. Brendel, H. Rinneberg and T. Nielsen, "Investigation of detection limits for diffuse optical tomography systems: II. Analysis of slab and cup geometry for breast imaging", Phys. Med. Biol. 54, 413 (2009). doi:10.1088/0031-9155/54/2/016
51. V. Ntziachristos, A.G. Yodh, M. Schnall and B. Chance, "Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement", Proc. Natl. Acad. Sci. USA 97, 2767 (2000). doi:10.1073/pnas.040570597 (Pubitemid 30159246)
52. X. Intes, J. Ripoll, Y. Chen, S. Nioka, A.G. Yodh and B. Chance, "In vivo continuous-wave optical breast imaging enhanced with indocyanine green", Med. Phys. 30, 1039 (2003). doi:10.1118/1.1573791 (Pubitemid 36735969)
53. A. Poellinger, S. Burock, D. Grosenick, A. Hagen, L. Lüdemann, F. Diekmann, F. Engelken, R. Macdonald, H. Rinneberg and P.M. Schlag, "Breast cancer: early-and late-fluorescence near-infrared imaging with indocyanine green-A preliminary study", Radiology 258, 409 (2011). doi:10.1148/radiol. 10100258
54. H. Rinneberg, D. Grosenick, K.T. Moesta, H. Wabnitz, J. Mucke, G. Wübbeler, R. Macdonald and P. Schlag, "Detection and characterization of breast tumours by time-domain scanning optical mammography", Opto-Electron. Rev. 16, 147 (2008). doi:10.2478/s11772-008-0004-5
55. A. Corlu, R. Choe, T. Durduran, M.A. Rosen, M. Schweiger, S.R. Arridge, M.D. Schnall and A.G. Yodh, "Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans", Opt. Expr. 15, 6696 (2007). doi:10.1364/OE.15.006696 (Pubitemid 46827669)
56. A. Hagen, D. Grosenick, R. Macdonald, H. Rinneberg, S. Burock, P. Warnick, A. Poellinger and P.M. Schlag, "Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions", Opt. Expr. 17, 17016 (2009). doi:10.1364/OE.17.017016
57. D. Grosenick, A. Hagen, O. Steinkellner, A. Poellinger, S. Burock, P.M. Schlag, H. Rinneberg and R. Macdonald, "A multichannel time-domain scanning fluorescence mammograph: Performance assessment and first in vivo results", Rev. Sci. Instrum. 82, 024302 (2011). doi:10.1063/1.3543820
58. M.R. Dreher, W. Liu, C.R. Michelich, M.W. Dewhirst, F. Yuan and A. Chilkoti, "Tumor vascular permeability, accumulation and penetration of macromolecular drug carriers", J. Natl. Cancer Inst. 98, 335 (2006). doi:10.1093/jnci/djj070 (Pubitemid 43338213)
59. P.S. Tofts, G. Brix, D.L. Buckley, J.L. Evelhoch, E. Henderson, M.V. Knopp, H.B.W. Larsson, T.-Y. Lee, N.A. Mayr, G.J.M. Parker, R.E. Port, J. Taylor and R.M. Weisskoff, "Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols", J. Magn. Reson. Imaging 10, 223 (1999). doi:10.1002/(SICI) 1522-2586 (199909) 10:3<223::AID-JMRI2>3.0. CO;2-S
60. H.E. Daldrup-Link and R.C. Brasch, "Macromolecular contrast agents for MR mammography: current status", Eur. Radiol. 13, 354 (2003). doi:10.1007/s00330-002-1719-1
61. M.R. Dreher, W. Liu, C.R. Michelich, M.W. Dewhirst, F. Yuan and A. Chilkoti, "Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers", J. Natl. Cancer Inst. 98, 335 (2006). doi:10.1093/jnci/djj070 (Pubitemid 43338213)
62. J.A. Chalela, C.S. Kidwell, L.M. Nentwich, M. Luby, J.A. Butman, A.M. Demchuk, M.D. Hill, N. Patronas, L. Latour and S. Warach, "Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison", Lancet 369, 293 (2007). doi:10.1016/S0140-6736 (07) 60151-2
63. J. Olesen, O.B. Paulson and N.A. Lassen, "Regional cerebral blood flow in man determined by the initial slope of the clearance of intraarterially injected 133Xe", Stroke 2, 519 (1971). doi:10.1161/01. STR.2.6.519
64. W.L. Wright, "Multimodal monitoring in the ICU: when could it be useful?", J. Neurol. Sci. 261, 10 (2007). doi:10.1016/j.jns.2007.04.027 (Pubitemid 47313491)
65. J.M. Colacino, B. Grubb and F.F. Jöbsis, "Infra-red technique for cerebral blood fow: Comparison with 133Xenon clearance", Neurol. Res. 3, 17 (1981).
66. M. Ferrari, D.A. Wilson, D.F. Hanley and R.J. Traystman, "Effects of graded hypotension on cerebral blood fow, blood volume and mean transit time in dogs", Am. J. Physiol. 262, H1908 (1992).
67. W.M. Kuebler, A. Sckell, O. Habler, M. Kleen, G.E.H. Kuhnle, M. Welte, K. Messmer and A.E. Goetz, "Noninvasive measurement of regional cerebral blood flow by near-infrared spectroscopy and indocyanine green", J. Cereb. Blood Flow Metab. 18, 445 (1998). doi:10.1097/00004647-199804000-00013
68. M. Diop, K. Verdecchia, T.-Y. Lee and K. St Lawrence, "Calibration of diffuse correlation spectroscopy with a time-resolved near-infrared technique to yield absolute cerebral blood flow measurements", Biomed. Opt. Expr. 2, 2068 (2011). doi:10.1364/BOE.2.002068
69. F. Gora, S. Shinde, C.E. Elwell, J.C. Goldstone, M. Cope, D.T. Delpy and M. Smith, "Noninvasive measurement of cerebral blood flow in adults using nearinfrared spectroscopy and indocyanine green: A pilot study", J. Neurosurg. Anesthesiol. 14, 218 (2002). doi:10.1097/00008506-200207000-00008 (Pubitemid 34756058)
70. E. Keller, A. Nadler, H. Alkadhi, S.S. Kollias, Y. Yonekawa and P. Niederer, "Noninvasive measurement of regional cerebral blood flow and regional cerebral blood volume by near-infrared spectroscopy and indocyanine green dye dilution", NeuroImage 20, 828 (2003). doi:10.1016/S1053-8119 (03) 00315-X
71. M. Kohl-Bareis, H. Obrig, J. Steinbrink, J. Malak, K. Uludag and A. Villringer, "Noninvasive monitoring of cerebral blood flow by a dye bolus method: Separation of brain from skin and skull signals", J. Biomed. Opt. 7, 464 (2002). doi:10.1117/1.1482719
72. C. Terborg, S. Bramer, S. Harscher, M. Simon and O.W. Witte, "Bedside assessment of cerebral perfusion reductions in patients with acute ischaemic stroke by near-infrared spectroscopy and indocyanine green", J. Neurol. Neurosurg. Psychiatry 75, 38 (2004).
73. J. Steinbrink, H. Wabnitz, H. Obrig, A. Villringer and H. Rinneberg, "Determining changes in NIR absorption using a layered model of the human head", Phys. Med. Biol. 46, 879 (2001). doi:10.1088/0031-9155/46/3/320 (Pubitemid 32218868)
74. A. Liebert, H. Wabnitz, J. Steinbrink, M. Moeller, R. Macdonald, H. Rinneberg, A. Villringer and H. Obrig, "Bed-side assessment of cerebral perfusion in stroke patients based on optical monitoring of a dye bolus by time-resolved diffuse reflectance", Neuro Image 24, 426 (2005). doi:10.1016/j.neuroimage.2004.08.046 (Pubitemid 41359038)
75. A. Liebert, H. Wabnitz, J. Steinbrink, H. Obrig, M. Moeller, R. Macdonald, A. Villringer and H. Rinneberg, "Time-resolved multidistance near-infrared spectroscopy of the adult head: intracerebral and extracerebral absorption changes from moments of distribution of times of flight of photons", Appl. Opt. 43, 3037 (2004). doi:10.1364/AO.43.003037
76. O. Steinkellner, C. Gruber, H. Wabnitz, A. Jelzow, J. Steinbrink, J.B. Fiebach and R. Macdonald, "Optical bedside monitoring of cerebral perfusion: Technological and methodological advances applied in a study on acute ischemic stroke", J. Biomed. Opt. 15, 061708 (2010). doi:10.1117/1.3505009
77. C. Terborg, K. Gröschel, A. Petrovitch, T. Ringer, S. Schnaudigel, O.W. Witte and A. Kastrup, "Noninvasive assessment of cerebral perfusion and oxygenation in acute ischemic stroke by near-infrared spectroscopy", Eur. Neurol. 62, 338 (2009). doi:10.1159/000239794
78. I. Roberts, P. Fallon, F.J. Kirkham, A. Lloyd-Thomas, C. Cooper, R. Maynard, M. Elliot and A.D. Edwards, "Estimation of cerebral blood flow with near infrared spectroscopy and indocyanine green", Lancet 342, 1425 (1993). doi:10.1016/0140-6736 (93) 92786-S (Pubitemid 23361260)
79. I.G. Roberts, P. Fallon, F.J. Kirkham, P.M. Kirshbom, C.E. Cooper, M.J. Elliott and A.D. Edwards, "Measurement of cerebral blood flow during cardiopulmonary bypass with near-infrared spectroscopy", J. Thorac. Cardiovasc. Surg. 115, 94 (1998). doi:10.1016/S0022-5223 (98) 70447-7
80. J. Steinbrink, T. Fischer, H. Kuppe, R. Hetzer, K. Uludag, H. Obrig and W.M. Kuebler, "Relevance of depth resolution for cerebral blood flow monitoring by near-infrared spectroscopic bolus tracking during cardiopulmonary bypass", J. Thorac. Cardiovasc. Surg. 132, 1172 (2006). doi:10.1016/j.jtcvs.2006.05.065 (Pubitemid 44584962)
81. H.W. Schytz, T. Wienecke, L.T. Jensen, J. Selb, D.A. Boas and M. Ashina, "Changes in cerebral blood flow after acetazolamide: an experimental study comparing near-infrared spectroscopy and SPECT", Eur. J. Neurol. 16, 461 (2009). doi:10.1111/j.1468-1331.2008.02398.x
82. G. Settakis, C. Molnar, L. Kerenyi, J. Kollar, D. Legemate, L. Csiba and B. Fülesdi, "Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature", Eur. J. Neurol. 10, 609 (2003). doi:10.1046/j.1468-1331.2003. 00675.x (Pubitemid 38030869)
83. I. Tachtsidis, T.S. Leung, M. Tisdall, D.T. Delpy, M. Smith and C.E. Elwell, "Cerebral blood flow assessment with indocyanine green bolus transit detection by nearinfrared spectroscopy before and after acetazolamide provocation in humans", in Biomedical Optics 2006Technical Digest. Optical Society of America, Washington, DC, USA, ME67 (2006).
84. E. Keller, J. Froehlich, C. Muroi, C. Sikorski and M. Muser, "Neuromonitoring in intensive care: a new brain tissue probe for combined monitoring of intracranial pressure (ICP), cerebral blood flow (CBF) and oxygenation", Acta Neurochir. Suppl. 110(Pt. 2), 217 (2011). doi:10.1007/978-3-7091-0356-2-39
85. A. Liebert, H. Wabnitz, H. Obrig, R. Erdmann, M. Moeller, R. Macdonald, H. Rinneberg, A. Villringer and J. Steinbrink, "Non-invasive detection of fluorescence from exogenous chromophores in the adult human brain", NeuroImage 31, 600 (2006). doi:10.1016/j.neuroimage.2005.12.046 (Pubitemid 43776652)
86. A. Liebert, H. Wabnitz, N. Zolek and R. Macdonald, "Monte Carlo algorithm for efficient simulation of timeresolved fluorescence in layered turbid media", Opt. Expr. 16, 13188 (2008). doi: 10.1364/O E.16. 013188
87. J. Steinbrink, A. Liebert, H. Wabnitz, R. Macdonald, H. Obrig, A. Wunder, R. Bourayou, T. Betz, J. Klohs, U. Lindauer, U. Dirnagl and A. Villringer, "Towards noninvasive molecular fluorescence imaging of the human brain", Neurodegener. Dis. 5, 296 (2008). doi:10.1159/000135614 (Pubitemid 351787052)
88. B. Ebert, J. Berger, J. Voigt, R. Macdonald, T. Fischer, K.-G. Hermann, K. Licha and M. Schirner, "Early detection of rheumatoid arthritis in humans by fluorescence imaging", in Biomedical Optics (CD-ROM). The Optical Society of America, Washington, DC, USA, BTuF19 (2008).
89. T. Fischer, B. Ebert, J. Voigt, R. Macdonald, U. Schneider, A. Thomas, B. Hamm, and K.-G.A. Hermann, "Detection of rheumatoid arthritis using non-specific contrast enhanced fluorescence imaging", Acad. Radiol. 17, 375 (2010). doi:10.1016/j.acra.2009.09.016
90. S. Merkesdal, J. Ruof, O. Schoffski, K. Bernitt, H. Zeidler and W. Mau, "Indirect medical costs in early rheumatoid arthritis: Composition of and changes in indirect costs within the first three years of disease", Arthritis Rheum. 44, 528 (2001). doi:10.1002/1529-0131 (200103) 44:3<528::AID-ANR100>3.0. CO;2-U
91. M. Østergaard, S.J. Pedersen and U.M. Døhn, "Imaging in rheumatoid arthrtitis: Status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography", Best Pract. Res. Clin. Rheumatol. 22, 1019 (2008). doi:10.1016/j.berh.2008.09.014
92. M. Backhaus, T. Kamradt, D. Sandrock, D. Loreck, J. Fritz, K.J. Wolf, J.H. Raber, B. Hamm, G.-R. Burmester and M. Bollow, "Arthritis of the finger joints: A comprehensive approach comparing conventional radio graphy, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging", Arthritis Rheum. 42, 1232 (1999). doi:10.1002/1529-0131 (199906) 42:6<1232::AID-ANR21>3.0. CO;2-3
93. T. de Zordo, S.P. Mlekusch, G.M. Feuchtner, E. Mur, M. Schirmer and A.S. Klauser, "Value of contrast-enhanced ultrasound in rheumatoid arthritis", Eur. J. Radiol. 64, 222 (2007). doi:10.1016/j.ejrad.2007.07.011 (Pubitemid 47588751)
94. M. Backhaus, "Ultrasound and structural changes in infammatory arthritis: synovitis and tenosynovitis", Ann. N.Y. Acad. Sci. 1154, 139 (2009). doi:10.1111/j.1749-6632.2009.04388.x
95. A. Wunder, R.H. Straub, S. Gay, J. Funk and U. Muller-Ladner, "Molecular imaging: Novel tools in visualizing rheumatoid arthritis", Rheumatology (Oxford) 44, 1341 (2005). doi:10.1093/rheumatology/keh709 (Pubitemid 41637634)
96. T. Fischer, I. Gemeinhardt, S. Wagner, D. von Stieglitz, J. Schnorr, K.G.A. Herrmann, B. Ebert, D. Petzelt, R. Macdonald, K. Licha, M. Schirner, V. Krenn, T. Kamradt and M. Taupitz, "Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis", Acad. Radiol. 13, 4 (2006). doi:10.1016/j.acra.2005.07.010 (Pubitemid 43041889)
97. C. Bremer, S. Werner and H.-E. Langer, "Assessing activity of rheumatic arthritis with fluorescence optical imaging", Eur. Musculoskelet. Rev. 4, 96 (2009).
98. T. Dziekan, C. Weissbach, J. Voigt, B. Ebert, R. Macdonald, M.L. Bahner, M. Mahler, M. Schirner, M. Berliner, B. Berliner, J. Osel and I. Osel, "Detection of rheumatoid arthritis by evaluation of normalized variances of fluorescence time correlation functions", J. Biomed. Opt. 16, 076015 (2011). doi:10.1117/1.3599958
99. S.G. Werner, H.-E. Langer and G. Horneff, "Fluorescence optical imaging of juvenile arthritis", J. Rheumatol. 38, 1447 (2011). doi:10.3899/jrheum.101351